
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5694736
[patent_doc_number] => 20060154883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Nonsense-mediated mrna decay'
[patent_app_type] => utility
[patent_app_number] => 10/525273
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 51595
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525273 | Nonsense-mediated mrna decay | Aug 20, 2003 | Abandoned |
Array
(
[id] => 5199703
[patent_doc_number] => 20070299021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Modified Tailed Oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/524724
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20471
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524724 | Modified Tailed Oligonucleotides | Aug 17, 2003 | Abandoned |
Array
(
[id] => 243181
[patent_doc_number] => 07588915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Isolated genomic polynucleotide fragments from chromosome 7'
[patent_app_type] => utility
[patent_app_number] => 10/642946
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12822
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/588/07588915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642946 | Isolated genomic polynucleotide fragments from chromosome 7 | Aug 17, 2003 | Issued |
Array
(
[id] => 7256224
[patent_doc_number] => 20050143331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Antisense modulation of phospholipase A2, group IIA (synovial) expression'
[patent_app_type] => utility
[patent_app_number] => 10/643038
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26695
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643038 | Antisense modulation of phospholipase A2, group IIA (synovial) expression | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7515536
[patent_doc_number] => 08039608
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-10-18
[patent_title] => 'Bioinformatically detectable group of novel regulatory genes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/604726
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 37
[patent_no_of_words] => 9619
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039608.pdf
[firstpage_image] =>[orig_patent_app_number] => 10604726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/604726 | Bioinformatically detectable group of novel regulatory genes and uses thereof | Aug 12, 2003 | Issued |
Array
(
[id] => 7170367
[patent_doc_number] => 20040077834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Nucleic acid molecules encoding DRT111 and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/639037
[patent_app_country] => US
[patent_app_date] => 2003-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28038
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10639037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/639037 | Nucleic acid molecules encoding DRT111 and uses thereof | Aug 10, 2003 | Abandoned |
Array
(
[id] => 7117191
[patent_doc_number] => 20050070492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Treating cancer using antisense oligonucleotides against telomerase reverse transcriptase'
[patent_app_type] => utility
[patent_app_number] => 10/637443
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7668
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10637443
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/637443 | Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase | Aug 7, 2003 | Issued |
Array
(
[id] => 397744
[patent_doc_number] => 07294713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Antisense IAP oligonucleotides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/636065
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 33
[patent_no_of_words] => 16942
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294713.pdf
[firstpage_image] =>[orig_patent_app_number] => 10636065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/636065 | Antisense IAP oligonucleotides and uses thereof | Aug 6, 2003 | Issued |
Array
(
[id] => 7397587
[patent_doc_number] => 20040038925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Inhibition of complement activation and complement modulation by use of modified oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/636452
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20427
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10636452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/636452 | Inhibition of complement activation and complement modulation by use of modified oligonucleotides | Aug 6, 2003 | Abandoned |
Array
(
[id] => 6926472
[patent_doc_number] => 20050239728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Double stranded rna structures and constructs, and methods for generating and using the same'
[patent_app_type] => utility
[patent_app_number] => 10/522962
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 50437
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522962 | Double stranded rna structures and constructs, and methods for generating and using the same | Jul 30, 2003 | Abandoned |
Array
(
[id] => 7400077
[patent_doc_number] => 20040023386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Modulation of nitric oxide synthase by PKC'
[patent_app_type] => new
[patent_app_number] => 10/629928
[patent_app_country] => US
[patent_app_date] => 2003-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15077
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10629928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/629928 | Modulation of nitric oxide synthase by PKC | Jul 28, 2003 | Abandoned |
Array
(
[id] => 7352595
[patent_doc_number] => 20040048378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Modulation of homologous recombination with single stranded dna binding proteins'
[patent_app_type] => new
[patent_app_number] => 10/380688
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5741
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380688
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380688 | Modulation of homologous recombination with single stranded dna binding proteins | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7318967
[patent_doc_number] => 20040224913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Antisense oligomers'
[patent_app_type] => new
[patent_app_number] => 10/624447
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12928
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624447 | Antisense oligomers | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7449892
[patent_doc_number] => 20040067588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate'
[patent_app_type] => new
[patent_app_number] => 10/250632
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6744
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067588.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250632
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250632 | Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate | Jul 2, 2003 | Abandoned |
Array
(
[id] => 7358578
[patent_doc_number] => 20040014122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Detection of spore forming bacteria'
[patent_app_type] => new
[patent_app_number] => 10/608062
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8335
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10608062
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/608062 | Detection of spore forming bacteria | Jun 26, 2003 | Abandoned |
Array
(
[id] => 7434403
[patent_doc_number] => 20040266706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Cross-linked oligomeric compounds and their use in gene modulation'
[patent_app_type] => new
[patent_app_number] => 10/606510
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33537
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266706.pdf
[firstpage_image] =>[orig_patent_app_number] => 10606510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/606510 | Cross-linked oligomeric compounds and their use in gene modulation | Jun 25, 2003 | Abandoned |
Array
(
[id] => 7402377
[patent_doc_number] => 20040175375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer'
[patent_app_type] => new
[patent_app_number] => 10/463676
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 11473
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10463676
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/463676 | Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer | Jun 17, 2003 | Issued |
Array
(
[id] => 7019309
[patent_doc_number] => 20050221328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Inhibitors of inflammatory gene activity and cholesterol biosynthesis'
[patent_app_type] => utility
[patent_app_number] => 10/517695
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 25483
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221328.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517695 | Inhibitors of inflammatory gene activity and cholesterol biosynthesis | Jun 12, 2003 | Abandoned |
Array
(
[id] => 5843052
[patent_doc_number] => 20060121466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Hammerhead ribozymes'
[patent_app_type] => utility
[patent_app_number] => 10/517638
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 21930
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517638 | Hammerhead ribozymes | Jun 11, 2003 | Abandoned |
Array
(
[id] => 5172614
[patent_doc_number] => 20070073047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Genes overexpressed by ovarian cancer and their use in developing novel therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/530951
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31599
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20070073047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530951 | Genes overexpressed by ovarian cancer and their use in developing novel therapeutics | Jun 9, 2003 | Abandoned |